ABD Device

Emergency response against dangerous pathogens & viruses


The delivery of countermeasures to sites of need is critically important to first responders and defence organisations. PCT is a robust technology that lends itself well to the concept of distributed mobile manufacturing. This provides a solution to logistical issues, including the transportation challenges of MCMs, which are synonymous with crises and pandemics.  Aquila Bioscience is investigating the potential of digital distribution of PCT, which may be tailored to the relevant biopathogen, or chemo pathogen required urgently in hostile or challenging environments. Advancing this technology, Aquila Bioscience has the capacity to deliver our highly effective product in a timely manner to support first-line responders and defence personnel on the ground. Moreover, the infrastructure could also be applied to other MCMs where necessary.